Key Findings
The Europe pharmaceutical continuous manufacturing market is predicted to record a CAGR of 9.97% during the forecast period, 2021-2028. The rich presence of key players, developed infrastructure with regard to pharmaceutical industries, and the availability of trained professionals to handle complex manufacturing systems, are expected to drive the market growth.

Market Insights
The Europe pharmaceutical continuous manufacturing market growth assessment includes the analysis of France, Germany, Poland, the United Kingdom, Belgium, Italy, Russia, and Rest of Europe. Germany is a top international location for the research, distribution, and production of pharmaceuticals. The market prospects are enhanced by the direct access to excellent research units, major pharmaceutical markets, and internationally renowned scientists. Germany also has one of the strongest healthcare systems with regard to advanced infrastructure. Moreover, there has been a gradual shift from batch to continuous manufacturing in recent years. Such factors are estimated to influence market growth.
France is a huge consumer of pharmaceutical products, and also a complex market to commercialize pharmaceutical products. The country has the highest consumption of medicines worldwide. The pharmaceutical sector is ranked fourth globally as per the INSEE, the French statistical office, and the French Ministry of Industry. In Belgium, pharmaceuticals account for more than 10% of the country’s total exports. The country is also one of the world leaders in the pharmaceutical industry. There have been huge investments by the government to develop this sector, along with promoting R&D. Such factors are expected to positively impact the market growth.

Competitive Insights
Some of the eminent players in the market include, Glatt GmbH, Coperion GmbH, Korsch AG, Hosokawa Micron Corporation, Siemens Healthineers, Eli Lilly & Company, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments